Wait goes on for Cann Global investors but firm insists deal ‘in final stages’ by Steve Jones February 28, 2024February 28, 2024 Cann Global has claimed it is close to finalising the terms of a potential transaction, 18 […]
Vitura looks to combat price war with further expansion ‘beyond medicinal cannabis’ by Steve Jones February 28, 2024February 28, 2024
Medibis embarks on fresh capital raise ahead of autism clinical trial by Steve Jones February 23, 2024February 28, 2024
We’ll bring innovation and research to Australia, says Charlotte’s Web co-founder as products prepare to launch by Steve Jones February 22, 2024February 22, 2024
ECS Botanics chases in-house product growth after A$4m capital raise by Steve Jones February 22, 2024February 22, 2024
Industry in the spotlight as regulators unite to explore rise in prescriptions by Steve Jones February 22, 2024February 22, 2024
The high-THC debate: ‘This is a medical market. It shouldn’t be consumer driven’ by Steve Jones February 21, 2024February 21, 2024
Specialist warns of ‘hidden’ issue of addiction as evidence gap remains ‘huge’ by Steve Jones February 20, 2024February 20, 2024
Administrators slim down Epsilon board as investigations continue by Steve Jones February 15, 2024February 15, 2024
Growers’ worst nightmare: Hop Latent Viroid detected in Australia by Steve Jones February 15, 2024February 15, 2024
